Eli Lilly's GLP-1 drug tirzepatide yields greater weight loss on average than Novo Nordisk's semagl...
Novo weight-loss drug may preserve lean body mass better than Lilly's, study finds
Eli Lilly's GLP-1 drug tirzepatide yields greater weight loss on average than Novo Nordisk's semaglutide, but at a greater expense to muscles and...
Author: Reuters
Read Original Article